Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes in a large generalisable population? A retrospective cohort study in the USA

Griffin, D., McNeil, C., Okusa, J., Berrent, D., Guo, Y., & Daugherty, S. E. (2023). Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes in a large generalisable population? A retrospective cohort study in the USA. BMJ Open, 13(8), e069247. https://doi.org/10.1136/bmjopen-2022-069247
Authors:
Daniel Griffin
Chace McNeil
James Okusa
Diana Berrent
Yinglong Guo
Sarah E Daugherty
Affiliated Authors:
Daniel Griffin
Subjects:
COVID-19 (MeSH)
Author Keywords:
covid-19
infectious diseases
virology
Publication Type:
Article
Unique ID:
10.1136/bmjopen-2022-069247
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: